{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:25:43Z","timestamp":1794558343628,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81871720"],"award-info":[{"award-number":["No. 81871720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82072363"],"award-info":[{"award-number":["No. 82072363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009576","name":"Nantong Municipal Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["QA2020027"],"award-info":[{"award-number":["QA2020027"]}],"id":[{"id":"10.13039\/501100009576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastric cancer (GC) is one of the diseases that endanger human health with high morbidity and mortality. The positive rates of traditional biomarkers in the diagnosis of GC are low, so it is necessary to find biomarkers with high sensitivity to increase the detection rate. tRNA-derived small RNAs (tsRNAs) are novel small non-coding RNAs with specific biological functions and aberrant expression in cancer. In this study, we focused on the potential of tRNA-derived small RNAs as GC biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The differentially expressed tsRNAs in three pairs of GC tissues were screened with high-throughput sequencing and verified using the TCGA database and Quantitative real-time PCR. The methodological evaluation of tRF-23-Q99P9P9NDD was verified by agarose gel electrophoresis, RIN evaluation, and Sanger sequencing. The Chi-square test was used to evaluate the relationship between the tRF-23-Q99P9P9NDD expression and clinicopathological parameters. Kaplan\u2013Meier survival analysis was used to evaluate the effect of the tRF-23-Q99P9P9NDD expression on survival. Additionally, the receiver operating characteristic curve (ROC) was used to evaluate the diagnostic efficacy of tRF-23-Q99P9P9NDD in GC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Differential expression of serum tRF-23-Q99P9P9NDD could distinguish GC patients from gastritis patients and healthy donors. Chi-square test showed that high expression of tRF-23-Q99P9P9NDD was significantly associated with T stage, lymph node metastasis, TNM stage, and nerve\/vascular invasion. Kaplan\u2013Meier curve showed that patients with high expression of tRF-23-Q99P9P9NDD had a lower survival rate than patients with low expression of this biomarker. ROC analysis showed that, compared with conventional biomarkers, the efficacy of tRF-23-Q99P9P9NDD was higher, which was improved by the combination of biomarkers, and even in the early stages. Finally, we preliminarily predicted the downstream of tRF-23-Q99P9P9NDD in GC cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The expression of tRF-23-Q99P9P9NDD in GC serum can identify GC patients, and it has higher efficacy than conventional biomarkers even in the early stages. Furthermore, tRF-23-Q99P9P9NDD can monitor the postoperative conditions of GC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-022-00491-8","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T06:02:44Z","timestamp":1654927364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancer"],"prefix":"10.1186","volume":"28","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-2371","authenticated-orcid":false,"given":"Shaoqing","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"issue":"23","key":"491_CR1","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1016\/j.febslet.2014.09.001","volume":"588","author":"P Anderson","year":"2014","unstructured":"Anderson P, Ivanov P. tRNA fragments in human health and disease. FEBS Lett. 2014;588(23):4297\u2013304.","journal-title":"FEBS Lett"},{"key":"491_CR2","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.12659\/MSM.915100","volume":"25","author":"Y Chao","year":"2019","unstructured":"Chao Y, Zhou D. lncRNA-D16366 is a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma. Med Sci Monit. 2019;25:6581\u20136.","journal-title":"Med Sci Monit"},{"issue":"6271","key":"491_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.aad7977","volume":"351","author":"Q Chen","year":"2016","unstructured":"Chen Q, Yan M, Cao Z, Li X, Zhang Y, Shi J, et al. Sperm tsRNAs contribute to intergenerational inheritance of an acquired metabolic disorder. Science. 2016;351(6271):397\u2013400.","journal-title":"Science"},{"issue":"12","key":"491_CR4","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.celrep.2018.11.073","volume":"25","author":"NT Chiou","year":"2018","unstructured":"Chiou NT, Kageyama R, Ansel KM. Selective export into extracellular vesicles and function of tRNA fragments during T cell activation. Cell Rep. 2018;25(12):3356-3370.e3354.","journal-title":"Cell Rep"},{"issue":"6","key":"491_CR5","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1002\/jcp.27533","volume":"234","author":"Y Cui","year":"2019","unstructured":"Cui Y, Huang Y, Wu X, Zheng M, Xia Y, Fu Z, et al. Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer. J Cell Physiol. 2019;234(6):8740\u201351.","journal-title":"J Cell Physiol"},{"issue":"6","key":"491_CR6","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.ejca.2010.02.013","volume":"46","author":"AE Dassen","year":"2010","unstructured":"Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer (oxford, England: 1990). 2010;46(6):1101\u201310.","journal-title":"Eur J Cancer (oxford, England: 1990)"},{"issue":"7","key":"491_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11894-016-0506-0","volume":"18","author":"CM den Hoed","year":"2016","unstructured":"den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18(7):34.","journal-title":"Curr Gastroenterol Rep"},{"key":"491_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/1471-2164-14-298","volume":"14","author":"JM Dhahbi","year":"2013","unstructured":"Dhahbi JM, Spindler SR, Atamna H, Yamakawa A, Boffelli D, Mote P, et al. 5\u2032 tRNA halves are present as abundant complexes in serum, concentrated in blood cells, and modulated by aging and calorie restriction. BMC Genomics. 2013;14:298.","journal-title":"BMC Genomics"},{"issue":"12","key":"491_CR9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"491_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.cell.2015.02.053","volume":"161","author":"H Goodarzi","year":"2015","unstructured":"Goodarzi H, Liu X, Nguyen HC, Zhang S, Fish L, Tavazoie SF. Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement. Cell. 2015;161(4):790\u2013802.","journal-title":"Cell"},{"issue":"1","key":"491_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-020-00971-6","volume":"13","author":"M Govindarajan","year":"2020","unstructured":"Govindarajan M, Wohlmuth C, Waas M, Bernardini MQ, Kislinger T. High-throughput approaches for precision medicine in high-grade serous ovarian cancer. J Hematol Oncol. 2020;13(1):134.","journal-title":"J Hematol Oncol"},{"key":"491_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fonc.2021.679366","volume":"11","author":"XL Gu","year":"2021","unstructured":"Gu XL, Ma S, Liang B, Ju SQ. Serum hsa_tsr016141 as a kind of tRNA-derived fragments is a novel biomarker in gastric cancer. Front Oncol. 2021;11:8.","journal-title":"Front Oncol"},{"issue":"5","key":"491_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2018.03.008","volume":"173","author":"N Guzzi","year":"2018","unstructured":"Guzzi N, Cie\u015bla M, Ngoc PCT, Lang S, Arora S, Dimitriou M, et al. Pseudouridylation of tRNA-derived fragments steers translational control in stem cells. Cell. 2018;173(5):1204-1216.e1226.","journal-title":"Cell"},{"issue":"1","key":"491_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13045-020-01005-x","volume":"13","author":"M Hong","year":"2020","unstructured":"Hong M, Tao S, Zhang L, Diao LT, Huang X, Huang S, et al. RNA sequencing: new technologies and applications in cancer research. J Hematol Oncol. 2020;13(1):166.","journal-title":"J Hematol Oncol"},{"issue":"41","key":"491_CR15","doi-asserted-by":"publisher","first-page":"11636","DOI":"10.3748\/wjg.v21.i41.11636","volume":"21","author":"Z Kalni\u0146a","year":"2015","unstructured":"Kalni\u0146a Z, Meistere I, Kikuste I, Tolmanis I, Zayakin P, Lin\u0113 A. Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol. 2015;21(41):11636\u201353.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"491_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.tibs.2016.05.004","volume":"41","author":"P Kumar","year":"2016","unstructured":"Kumar P, Kuscu C, Dutta A. Biogenesis and function of transfer RNA-related fragments (tRFs). Trends Biochem Sci. 2016;41(8):679\u201389.","journal-title":"Trends Biochem Sci"},{"issue":"18","key":"491_CR17","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.3748\/wjg.v20.i18.5411","volume":"20","author":"P-F Li","year":"2014","unstructured":"Li P-F, Chen S-C, Xia T, Jiang X-M, Shao Y-F, Xiao B-X, et al. Non-coding RNAs and gastric cancer. World J Gastroenterol. 2014;20(18):5411\u20139.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"491_CR18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1373\/clinchem.2017.285072","volume":"64","author":"F Li","year":"2018","unstructured":"Li F, Kaczor-Urbanowicz KE, Sun J, Majem B, Lo HC, Kim Y, et al. Characterization of human salivary extracellular RNA by next-generation sequencing. Clin Chem. 2018;64(7):1085\u201395.","journal-title":"Clin Chem"},{"key":"491_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2019.05.007","volume":"457","author":"D Mo","year":"2019","unstructured":"Mo D, Jiang P, Yang Y, Mao X, Tan X, Tang X, et al. A tRNA fragment, 5\u2032-tiRNA (Val), suppresses the Wnt\/\u03b2-catenin signaling pathway by targeting FZD3 in breast cancer. Cancer Lett. 2019;457:60\u201373.","journal-title":"Cancer Lett"},{"issue":"17","key":"491_CR20","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3748\/wjg.v25.i17.2029","volume":"25","author":"L Necula","year":"2019","unstructured":"Necula L, Matei L, Dragu D, Neagu AI, Mambet C, Nedeianu S, et al. Recent advances in gastric cancer early diagnosis. World J Gastroenterol. 2019;25(17):2029\u201344.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"491_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.5946\/ce.2014.47.6.478","volume":"47","author":"JY Park","year":"2014","unstructured":"Park JY, von Karsa L, Herrero R. Prevention strategies for gastric cancer: a global perspective. Clin Endosc. 2014;47(6):478\u201389.","journal-title":"Clin Endosc"},{"issue":"3","key":"491_CR22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.25100\/cm.v44i3.1263","volume":"44","author":"MB Piazuelo","year":"2013","unstructured":"Piazuelo MB, Correa P. Gastric cancer: overview. Colombia Medica. 2013;44(3):192\u2013201.","journal-title":"Colombia Medica"},{"issue":"5","key":"491_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/carcin\/bgx026","volume":"38","author":"G Romano","year":"2017","unstructured":"Romano G, Veneziano D, Acunzo M, Croce CM. Small non-coding RNA and cancer. Carcinogenesis. 2017;38(5):485\u201391.","journal-title":"Carcinogenesis"},{"issue":"1","key":"491_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrm.2017.77","volume":"19","author":"P Schimmel","year":"2018","unstructured":"Schimmel P. The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis. Nat Rev Mol Cell Biol. 2018;19(1):45\u201358.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"491_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/cbdd.12994","volume":"90","author":"Y Shao","year":"2017","unstructured":"Shao Y, Sun Q, Liu X, Wang P, Wu R, Ma Z. tRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer. Chem Biol Drug Des. 2017;90(5):730\u20138.","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"491_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","volume":"17","author":"H Shimada","year":"2014","unstructured":"Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer. 2014;17(1):26\u201333.","journal-title":"Gastric Cancer"},{"issue":"6","key":"491_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/00365521.2015.1019918","volume":"50","author":"P Sipponen","year":"2015","unstructured":"Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015;50(6):657\u201367.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"491_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-020-00945-8","volume":"13","author":"YM Sun","year":"2020","unstructured":"Sun YM, Chen YQ. Principles and innovative technologies for decrypting noncoding RNAs: from discovery and functional prediction to clinical application. J Hematol Oncol. 2020;13(1):109.","journal-title":"J Hematol Oncol"},{"key":"491_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2017.10.031","volume":"414","author":"C Sun","year":"2018","unstructured":"Sun C, Fu Z, Wang S, Li J, Li Y, Zhang Y, et al. Roles of tRNA-derived fragments in human cancers. Cancer Lett. 2018;414:16\u201325.","journal-title":"Cancer Lett"},{"issue":"3","key":"491_CR30","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2021;71(3):209\u201349.","journal-title":"CA"},{"key":"491_CR31","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.12659\/MSM.916475","volume":"25","author":"Z Tan","year":"2019","unstructured":"Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit. 2019;25:3537\u201341.","journal-title":"Med Sci Monit"},{"issue":"1","key":"491_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-021-01836-7","volume":"40","author":"EW Tao","year":"2021","unstructured":"Tao EW, Wang HL, Cheng WY, Liu QQ, Chen YX, Gao QY. A specific tRNA half, 5\u2032tiRNA-His-GTG, responds to hypoxia via the HIF1\u03b1\/ANG axis and promotes colorectal cancer progression by regulating LATS2. J Exp Clin Cancer Res. 2021;40(1):67.","journal-title":"J Exp Clin Cancer Res"},{"key":"491_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.570916","volume":"10","author":"L Tong","year":"2020","unstructured":"Tong L, Zhang W, Qu B, Zhang F, Wu Z, Shi J, et al. The tRNA-derived fragment-3017A promotes metastasis by inhibiting NELL2 in human gastric cancer. Front Oncol. 2020;10: 570916.","journal-title":"Front Oncol"},{"key":"491_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-019-0349-9","volume":"39","author":"FH Wang","year":"2019","unstructured":"Wang FH, Shen L, Li J, Zhou ZW, Liang H, Zhang XT, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun. 2019;39:1\u201331.","journal-title":"Cancer Commun"},{"issue":"7","key":"491_CR35","doi-asserted-by":"publisher","first-page":"23359","DOI":"10.1002\/jcla.23359","volume":"34","author":"YZ Wang","year":"2020","unstructured":"Wang YZ, Li Z, Xu SY, Guo JM. Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies. J Clin Lab Anal. 2020;34(7):23359.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"491_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41523-020-00211-7","volume":"7","author":"J Wang","year":"2021","unstructured":"Wang J, Ma G, Ge H, Han X, Mao X, Wang X, et al. Circulating tRNA-derived small RNAs (tsRNAs) signature for the diagnosis and prognosis of breast cancer. NPJ Breast Cancer. 2021;7(1):4.","journal-title":"NPJ Breast Cancer"},{"key":"491_CR37","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2013.16","volume":"16","author":"HH Wu","year":"2014","unstructured":"Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16: e1.","journal-title":"Expert Rev Mol Med"},{"issue":"1","key":"491_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/17474124.2019.1542299","volume":"13","author":"J-Y Wu","year":"2019","unstructured":"Wu J-Y, Lee Y-C, Graham DY. The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal. Expert Rev Gastroenterol Hepatol. 2019;13(1):17\u201324.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"491_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00217-4","volume":"5","author":"YY Xie","year":"2020","unstructured":"Xie YY, Yao LP, Yu XC, Ruan Y, Li Z, Guo JM. Action mechanisms and research methods of tRNA-derived small RNAs. Signal Transduct Target Therapy. 2020;5(1):1\u20139.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"491_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-018-0932-8","volume":"18","author":"H Xu","year":"2019","unstructured":"Xu H, Wang C, Song H, Xu Y, Ji G. RNA-Seq profiling of circular RNAs in human colorectal cancer liver metastasis and the potential biomarkers. Mol Cancer. 2019;18(1):8.","journal-title":"Mol Cancer"},{"key":"491_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.733763","volume":"11","author":"W Xu","year":"2021","unstructured":"Xu W, Zhou B, Wang J, Tang L, Hu Q, Wang J, et al. tRNA-derived fragment tRF-Glu-TTC-027 regulates the progression of gastric carcinoma via MAPK signaling pathway. Front Oncol. 2021;11: 733763.","journal-title":"Front Oncol"},{"issue":"1","key":"491_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00955-6","volume":"13","author":"MQ Yu","year":"2020","unstructured":"Yu MQ, Lu BJ, Zhang JS, Ding JW, Liu PY, Lu Y. tRNA-derived RNA fragments in cancer: current status and future perspectives. J Hematol Oncol. 2020;13(1):1\u201314.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"491_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7150\/thno.51963","volume":"11","author":"X Yu","year":"2021","unstructured":"Yu X, Xie Y, Zhang S, Song X, Xiao B, Yan Z. tRNA-derived fragments: mechanisms underlying their regulation of gene expression and potential applications as therapeutic targets in cancers and virus infections. Theranostics. 2021;11(1):461\u20139.","journal-title":"Theranostics"},{"key":"491_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108467","volume":"690","author":"F Zhang","year":"2020","unstructured":"Zhang F, Shi J, Wu Z, Gao P, Zhang W, Qu B, et al. A 3\u2032-tRNA-derived fragment enhances cell proliferation, migration and invasion in gastric cancer by targeting FBXO47. Arch Biochem Biophys. 2020;690: 108467.","journal-title":"Arch Biochem Biophys"},{"key":"491_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2019.03.012","volume":"452","author":"L Zhu","year":"2019","unstructured":"Zhu L, Ge J, Li T, Shen Y, Guo J. tRNA-derived fragments and tRNA halves: the new players in cancers. Cancer Lett. 2019a;452:31\u20137.","journal-title":"Cancer Lett"},{"issue":"1","key":"491_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-019-1000-8","volume":"18","author":"L Zhu","year":"2019","unstructured":"Zhu L, Li J, Gong Y, Wu Q, Tan S, Sun D, et al. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis. Mol Cancer. 2019b;18(1):74.","journal-title":"Mol Cancer"},{"issue":"3","key":"491_CR47","doi-asserted-by":"publisher","first-page":"12977","DOI":"10.1111\/cpr.12977","volume":"54","author":"TY Zong","year":"2021","unstructured":"Zong TY, Yang YY, Zhao H, Li L, Liu MX, Fu XX, et al. tsRNAs: novel small molecules from cell function and regulatory mechanism to therapeutic targets. Cell Prolif. 2021;54(3):12977.","journal-title":"Cell Prolif"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00491-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-022-00491-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00491-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T16:13:12Z","timestamp":1727367192000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-022-00491-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1186\/s10020-022-00491-8","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the local hospital (ethical review report number: 2018-L055) approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent obtained from study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}